S&P 500   4,546.79 (-0.07%)
DOW   35,688.96 (+0.24%)
QQQ   373.95 (-0.88%)
AAPL   148.99 (-0.33%)
MSFT   309.04 (-0.55%)
FB   322.42 (-5.69%)
GOOGL   2,752.66 (-3.00%)
TSLA   905.47 (+1.28%)
AMZN   3,343.88 (-2.65%)
NVDA   227.48 (+0.25%)
BABA   176.85 (-0.32%)
NIO   38.61 (-3.40%)
CGC   13.26 (-5.56%)
GE   104.22 (+1.04%)
AMD   119.77 (+0.37%)
MU   67.60 (-1.52%)
T   25.51 (-0.97%)
F   16.29 (-1.57%)
ACB   7.05 (-4.34%)
DIS   169.34 (-1.17%)
PFE   43.05 (+0.44%)
BA   212.96 (-0.64%)
AMC   36.28 (-7.54%)
S&P 500   4,546.79 (-0.07%)
DOW   35,688.96 (+0.24%)
QQQ   373.95 (-0.88%)
AAPL   148.99 (-0.33%)
MSFT   309.04 (-0.55%)
FB   322.42 (-5.69%)
GOOGL   2,752.66 (-3.00%)
TSLA   905.47 (+1.28%)
AMZN   3,343.88 (-2.65%)
NVDA   227.48 (+0.25%)
BABA   176.85 (-0.32%)
NIO   38.61 (-3.40%)
CGC   13.26 (-5.56%)
GE   104.22 (+1.04%)
AMD   119.77 (+0.37%)
MU   67.60 (-1.52%)
T   25.51 (-0.97%)
F   16.29 (-1.57%)
ACB   7.05 (-4.34%)
DIS   169.34 (-1.17%)
PFE   43.05 (+0.44%)
BA   212.96 (-0.64%)
AMC   36.28 (-7.54%)
S&P 500   4,546.79 (-0.07%)
DOW   35,688.96 (+0.24%)
QQQ   373.95 (-0.88%)
AAPL   148.99 (-0.33%)
MSFT   309.04 (-0.55%)
FB   322.42 (-5.69%)
GOOGL   2,752.66 (-3.00%)
TSLA   905.47 (+1.28%)
AMZN   3,343.88 (-2.65%)
NVDA   227.48 (+0.25%)
BABA   176.85 (-0.32%)
NIO   38.61 (-3.40%)
CGC   13.26 (-5.56%)
GE   104.22 (+1.04%)
AMD   119.77 (+0.37%)
MU   67.60 (-1.52%)
T   25.51 (-0.97%)
F   16.29 (-1.57%)
ACB   7.05 (-4.34%)
DIS   169.34 (-1.17%)
PFE   43.05 (+0.44%)
BA   212.96 (-0.64%)
AMC   36.28 (-7.54%)
S&P 500   4,546.79 (-0.07%)
DOW   35,688.96 (+0.24%)
QQQ   373.95 (-0.88%)
AAPL   148.99 (-0.33%)
MSFT   309.04 (-0.55%)
FB   322.42 (-5.69%)
GOOGL   2,752.66 (-3.00%)
TSLA   905.47 (+1.28%)
AMZN   3,343.88 (-2.65%)
NVDA   227.48 (+0.25%)
BABA   176.85 (-0.32%)
NIO   38.61 (-3.40%)
CGC   13.26 (-5.56%)
GE   104.22 (+1.04%)
AMD   119.77 (+0.37%)
MU   67.60 (-1.52%)
T   25.51 (-0.97%)
F   16.29 (-1.57%)
ACB   7.05 (-4.34%)
DIS   169.34 (-1.17%)
PFE   43.05 (+0.44%)
BA   212.96 (-0.64%)
AMC   36.28 (-7.54%)
OTCMKTS:WIZP

Mawson Infrastructure Group Stock Forecast, Price & News

$9.55
-0.23 (-2.35 %)
(As of 10/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.29
▼
$9.94
50-Day Range
$0.99
▼
$16.49
52-Week Range
$0.07
▼
$1.45
Volume165,556 shs
Average Volume141,517 shs
Market Capitalization$4.64 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.58
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive WIZP News and Ratings via Email

Sign-up to receive the latest news and ratings for Mawson Infrastructure Group and its competitors with MarketBeat's FREE daily newsletter.


Mawson Infrastructure Group logo

About Mawson Infrastructure Group

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company is headquartered in North Sydney, Australia.

Headlines

Mawson Infrastructure Group (OTCMKTS:WIZP) Reaches New 1-Year High at $9.74
October 18, 2021 |  americanbankingnews.com
Mawson Infrastructure Group (OTCMKTS:WIZP) Reaches New 52-Week High at $9.80
October 11, 2021 |  americanbankingnews.com
Why Amazon Cares If Weed Is legal
October 11, 2021 |  benzinga.com
Comparing Metacrine (NASDAQ:MTCR) & Mawson Infrastructure Group (OTCMKTS:WIZP)
October 6, 2021 |  americanbankingnews.com
Mawson Infrastructure Group (OTCMKTS:WIZP) Sets New 12-Month High at $10.13
October 4, 2021 |  americanbankingnews.com
Can MDMA (Or Ecstasy) Improve Sexual Desire in Women? MindCure Launches Research Program To Find Out
September 29, 2021 |  benzinga.com
Mawson Infrastructure Group (OTCMKTS:WIZP) Sets New 52-Week High at $12.17
September 27, 2021 |  americanbankingnews.com
Cheech Marin Teams Up With AF Life Sciences To Produce And Sell 'Cheech's Stash'
September 23, 2021 |  benzinga.com
US 9th Circuit Hears Historic Case To Allow Psilocybin Therapy
September 16, 2021 |  benzinga.com
CBD Brand Vybes Teams Up With PizzaSlime To Launch Limited Edition Watermelon Slime Beverage
September 14, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:WIZP
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
www.wizepharma.com
Phone
(128) 624-6130
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
318.33

Profitability

EPS (Most Recent Fiscal Year)
($0.37)
Net Income
$-3.45 million
Net Margins
N/A
Return on Equity
N/A
Return on Assets
-85.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.13
Quick Ratio
1.13

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
486,324,000
Market Cap
$4.64 billion
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Mawson Infrastructure Group (OTCMKTS:WIZP) Frequently Asked Questions

What stocks does MarketBeat like better than Mawson Infrastructure Group?

Wall Street analysts have given Mawson Infrastructure Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mawson Infrastructure Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Mawson Infrastructure Group's stock been impacted by COVID-19 (Coronavirus)?

Mawson Infrastructure Group's stock was trading at $0.2296 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WIZP shares have increased by 4,059.4% and is now trading at $9.55.
View which stocks have been most impacted by COVID-19.

Who are Mawson Infrastructure Group's key executives?

Mawson Infrastructure Group's management team includes the following people:
  • Or Eisenberg, Chief Financial Officer

What other stocks do shareholders of Mawson Infrastructure Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mawson Infrastructure Group investors own include Neos Therapeutics (NEOS), Verastem (VSTM), Cara Therapeutics (CARA), (CGC), Charlotte's Web (CWBHF), (IDN), Magic Software Enterprises (MGIC), PURE Bioscience (PURE), Sesen Bio (SESN) and Spero Therapeutics (SPRO).

What is Mawson Infrastructure Group's stock symbol?

Mawson Infrastructure Group trades on the OTCMKTS under the ticker symbol "WIZP."

How do I buy shares of Mawson Infrastructure Group?

Shares of WIZP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mawson Infrastructure Group's stock price today?

One share of WIZP stock can currently be purchased for approximately $9.55.

How much money does Mawson Infrastructure Group make?

Mawson Infrastructure Group has a market capitalization of $4.64 billion. The company earns $-3.45 million in net income (profit) each year or ($0.37) on an earnings per share basis.

How many employees does Mawson Infrastructure Group have?

Mawson Infrastructure Group employs 2 workers across the globe.

What is Mawson Infrastructure Group's official website?

The official website for Mawson Infrastructure Group is www.wizepharma.com.

Where are Mawson Infrastructure Group's headquarters?

Mawson Infrastructure Group is headquartered at 24 HANAGAR STREET, HOD HASHARON L3, 4527708.

How can I contact Mawson Infrastructure Group?

Mawson Infrastructure Group's mailing address is 24 HANAGAR STREET, HOD HASHARON L3, 4527708. The company can be reached via phone at (128) 624-6130.


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.